Shandong Cancer Hospital, Jinan, China.
Cancer Sci. 2012 Nov;103(11):1989-93. doi: 10.1111/cas.12001. Epub 2012 Oct 18.
Conventional procedures for the intraoperative assessment of breast cancer sentinel lymph nodes (SLNs) are frozen section (FS) and touch imprint cytology (TIC). The one-step nucleic acid amplification (OSNA) assay is a novel molecular technique. The aim of this study was to evaluate the optimal approach by comparing OSNA assay, FS, and TIC. Five hundred and fifty-two consecutive patients were enroled from five study centers in China. The SLNs were cut into alternating 2 mm blocks. The odd blocks were tested by the OSNA assay intraoperatively, and the even ones were assessed by postoperative histology (four 4- to 6-μm-thick sections were taken every 200 μm per block). In addition, intraoperative histological assessments were carried out on the even blocks of 211 patients by FS and all blocks of 552 patients by TIC. Overall performance of the assay compared to postoperative histology was: accuracy 91.4%; sensitivity 83.7%; and specificity 92.9%. The sensitivity of the assay was higher than FS (211 patients, 77.6% vs 69.7%; not significant, P = 0.286) and was significantly higher than TIC (552 patients, 83.6% vs 76.2%; P = 0.044). When assessing nodes with micrometastases, the sensitivity of the assay was higher than FS (17 nodes, 47.1% vs 23.5%; not significant, P = 0.289) and was significantly higher than TIC (48 nodes, 62.5% vs 35.4%; P = 0.007). The study indicated that the OSNA assay is an accurate and rapid intraoperative assay for assessing breast SLNs and it can replace FS and TIC for application in general medical practice. The trial was registered as: OSNA assay China Registration Study.
China Breast Cancer Clinical Study Group 001c.
常规的术中评估乳腺癌前哨淋巴结 (SLN) 的方法有冷冻切片 (FS) 和触印细胞学 (TIC)。一步法核酸扩增 (OSNA) 检测是一种新的分子技术。本研究旨在通过比较 OSNA 检测、FS 和 TIC 来评估最佳方法。从中国五个研究中心连续纳入 552 例患者。SLN 被切成交替的 2mm 块。奇数块在术中用 OSNA 检测进行检测,偶数块则通过术后组织学评估(每 200μm 取 4-6μm 厚的 4 个切片)。此外,211 例患者的偶数块进行 FS 术中组织学评估,552 例患者的所有块进行 TIC 评估。与术后组织学相比,该检测的整体性能为:准确性 91.4%;灵敏度 83.7%;特异性 92.9%。该检测的灵敏度高于 FS(211 例患者,77.6% vs 69.7%;无统计学意义,P=0.286),明显高于 TIC(552 例患者,83.6% vs 76.2%;P=0.044)。在评估有微转移的淋巴结时,该检测的灵敏度高于 FS(17 个淋巴结,47.1% vs 23.5%;无统计学意义,P=0.289),明显高于 TIC(48 个淋巴结,62.5% vs 35.4%;P=0.007)。该研究表明,OSNA 检测是一种准确、快速的术中检测方法,可替代 FS 和 TIC 用于一般医疗实践。该试验在中国注册为:OSNA 检测中国注册研究。
中国乳腺癌临床研究组 001c。